menu
    • menu
    [{"orgOrder":0,"company":"Navamedic","sponsor":"DNE Pharma","pharmaFlowCategory":"D","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Acquisition","leadProduct":"Naloxone Hydrochloride","moa":"Opioid receptors; mu\/kappa\/delta","graph1":"Psychiatry\/Psychology","graph2":"Approved FDF","graph3":"Navamedic","amount2":0.02,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Psychiatry","amount2New":0.02,"dosageForm":"Nasal Spray","sponsorNew":"Navamedic \/ Navamedic","highestDevelopmentStatusID":"15","companyTruncated":"Navamedic \/ Navamedic"}]

    Find Clinical Drug Pipeline Developments & Deals by Navamedic

    Menu

    Navamedic

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Navamedic

                            Norway arrow
                            ACS Fall 2025
                            Not Confirmed

                            Navamedic

                            Norway arrow
                            ACS Fall 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Naloxone Hydrochloride

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Approved FDF

                            Recipient : DNE Pharma

                            Deal Size : $22.2 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Navamedic Expands into Addiction Treatment through dne Pharma

                            Details : The Acquisition encompasses dne pharma's business, including product portfolio, such as Ventizolve (naloxone), Levopidon (levomethadone), and Metadon Dne (methadone) for opioid substitution therapy.

                            Product Name : Ventizolve

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            June 23, 2025

                            Lead Product(s) : Naloxone Hydrochloride

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Approved FDF

                            Recipient : DNE Pharma

                            Deal Size : $22.2 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth